
Empowered by the successful closure of our Series-A Financing Round counting 14.5 million CHF, we are boosting our path to market entry for the Surgical-Fiberlock™ technology!
For more information, please read our press release.

Empowered by the successful closure of our Series-A Financing Round counting 14.5 million CHF, we are boosting our path to market entry for the Surgical-Fiberlock™ technology!
For more information, please read our press release.
ZuriMED Technologies AG won the competition with the Project “A Novel Medical Device for Ligament Reconstruction”. Visit the website.
For the 4th time, the venture leaders jury has selected the venture leaders China team 2017, forming the “Swiss National…
The Zurich based startup ZuriMED, specialising in orthopaedic biomechanics, has earned the Innosuisse certificate, thanks to its revolutionary device for…
Important step toward expansion for ZuriMED Technologies AG We are thrilled to announce, that we received the Innosuisse Scale-up Award!…
ZuriMED is delighted to announce that our Innosuisse Project grant application has been approved, supporting the co-development with our research…
We are excited to announce that ZuriMED was selected as the winner of this year’s ATiO Early-Stage Pitch Contest in…
What an unforgettable journey to the 8th China (Shenzhen) Innovation and Entrepreneurship Competition! 🌟 We are incredibly proud to have…
Breaking News: Our FiberLocker® System has just received FDA clearance! We’re more than thrilled to announce that our innovative FiberLocker®…
Please choose your preferred region to continue.